Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients

Supportive Care in Cancer

Volumn 21, Issue 11, 2013, Pages 3179-3189

  Nicolatou Galitis, Ourania ^a   Sarri, Triantafyllia ^a   Bowen, Joanne ^b   Di Palma, Mario ^c   Kouloulias, Vassilios E ^d   Niscola, Pasquale ^e   Riesenbeck, Dorothea ^f   Stokman, Monique ^g   Tissing, Wim ^g   Yeoh, Eric ^b,h   Elad, Sharon ⁱ   Lalla, Rajesh V ^j  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^e S EUGENIO HOSPITAL   (Italy)

^f Radiation Oncology Practice   (Germany)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h ROYAL ADELAIDE HOSPITAL   (Australia)

ⁱ UNIVERSITY OF ROCHESTER   (United States)

^j UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

more..

Author keywords

Anti inflammatory agents; Guidelines; Oral mucositis; Systematic review

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; AMIFOSTINE; AMINOSALICYLIC ACID; AMLEXANOX; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BENZYDAMINE; BETAMETHASONE; CELECOXIB; CORTICOSTEROID; DEXAMETHASONE; DIPHENHYDRAMINE; FLURBIPROFEN; HISTAMINE; HYDROCORTISONE; IBUPROFEN; INDOMETACIN; INFLIXIMAB; LACTOFERRIN; MESALAZINE; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISONE; PROSTAGLANDIN E2; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR INHIBITOR; UNINDEXED DRUG;

CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER THERAPY; CHEMORADIOTHERAPY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; ERYTHEMA; HEAD AND NECK CANCER; HUMAN; MULTICENTER STUDY (TOPIC); ORAL MUCOSITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SYSTEMATIC REVIEW;

ANTI-INFLAMMATORY AGENTS; CHEMORADIOTHERAPY; HEAD AND NECK NEOPLASMS; HUMANS; MOUTHWASHES; PRACTICE GUIDELINES AS TOPIC; STOMATITIS;

EID: 84885668743     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1847-y     Document Type: Review

References (57)

1. Sonis ST (1998) Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 34:39-43
2. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9 Suppl):1995-2025
3. Xanthinaki A, Nicolatou-Galitis O, Athanassiadou P, Gonidi M, Kouloulias V, Sotiropoulou-Lontou A, Pissakas G, Kyprianou K, Kouvaris J, Patsouris E (2008) Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report. Support Care Cancer 16(9):1025-1033
4. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(9 Suppl):2026-2046
5. Lalla RV, Schubert MM, Bensadoun RJ, Keefe D (2006) Anti-inflammatory agents in the management of alimentary mucositis. Support Care Cancer 14(6):558-565
6. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109(5):820-831
7. Bowen JM, Elad S, Hutchins RD, Lalla RV (2013) Methodology for the MASCC/ISOO Mucositis Clinical Practice Guidelines Update. Support Care Cancer 21:303-308
8. Elad S, Bowen J, Zadik Y, Lalla RV (2013) Development of the MASCC/ISOO Clinical Practice Guidelines for Mucositis: considerations underlying the process. Support Care Cancer 21:309-312
9. Hadorn DC, Baker D, Hodges JS, Hicks N (1996) Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol 49(7):749-754
10. Somerfield MR, McCrae RR (2000) Stress and coping research. Methodological challenges, theoretical advances, and clinical applications. Am Psychol 55(6):620-6259
11. Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias V, Niscola P et al (2013) Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer 21:357-364
12. Epstein JB, Stevenson-Moore P (1986) Benzydamine hydrochloride in prevention and management of pain in oral mucositis associated with radiation therapy. Oral Surg Oral Med Oral Pathol 62:145-148
13. Samaranayake LP, Robertson AG, MacFarlane TW, Hunter IP, MacFarlane G, Soutar DS, Ferguson MM (1988) The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation. Clin Radiol 39:291-294
14. Epstein JB, Stevenson-Moore P, Jackson S, Mohamed JH, Spinelli JJ (1989) Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse. Int J Radiat Oncol Biol Phys 16:1571-1575
15. Epstein JB, Silverman S Jr, Paggiarino DA, Crockett S, Schubert MM, Senzer NN, Lockhart PB, Gallagher MJ, Peterson DE, Leveque FG (2001) Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer 92:875-885
16. Cheng KF, Ka Tsui Yuen J (2006) A pilot study of chlorhexidine and benzydamine oral rinses for the prevention and treatment of irradiation mucositis in patients with head and neck cancer. Cancer Nurs 29:423-430
17. Kazemian A, Kamian S, Aghili M, Hashemi FA, Haddad P (2009) Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial. Eur J Cancer Care 18:174-178
18. Kim JH, Chu F, Lakshmi V, Houde R (1985) A clinical study of benzydamine for the treatment of radiotherapy-induced mucositis of the oropharynx. Int J Tissue React 7:215-218
19. Kim JH, Chu FC, Lakshmi V, Houde R (1986) Benzydamine HCl, a new agent for the treatment of radiation mucositis of the oropharynx. Am J Clin Oncol 9:132-134
20. Prada A, Lozza L, Moglia D, Sala L, Chiesa F (1985) Effects of benzydamine on radio-polychemotherapeutic mucositis of the oral cavity. Int J Tissue React 7:237-239
21. Prada A, Chiesa F (1987) Effects of benzydamine on the oral mucositis during antineoplastic radiotherapy and/or intra-arterial chemotherapy. Int J Tissue React 9:115-119
22. Putwatana P, Sanmanowong P, Oonprasertpong L, Junda T, Pitiporn S, Narkwong L (2009) Relief of radiation-induced oral mucositis in head and neck cancer. Cancer Nurs 32:82-87
23. Cheng KK, Chang AM (2003) Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy. Cancer Nurs 26:476-484
24. Cheng KK, Chang AM, Yuen MP (2004) Prevention of oral mucositis in paediatric patients treated with chemotherapy; a randomised crossover trial comparing two protocols of oral care. Eur J Cancer 40:1208-1216
25. Cheng KK (2004) Children's acceptance and tolerance of chlorhexidine and benzydamine oral rinses in the treatment of chemotherapy-induced oropharyngeal mucositis. Eur J Oncol Nurs 8:341-349
26. Sonis ST, Clairmont F, Lockhart PB, Connolly SF (1985) Benzydamine HCL in the management of chemotherapy-induced mucositis I. Pilot study. J Oral Med 40:67-71
27. Schubert MM, Newton RE (1987) The use of benzydamine HCl for the management of cancer therapy-induced mucositis: preliminary report of a multicentre study. Int J Tissue React 9:99-103
28. Lever SA, Dupuis LL, Chan HS (1987) Comparative evaluation of benzydamine oral rinse in children with antineoplastic-induced stomatitis. Drug Intell Clin Pharm 21:359-361
29. Rothwell BR, Spektor WS (1990) Palliation of radiation-related mucositis. Spec Care Dentist 10:21-25
30. Carnel SB, Blakeslee DB, Oswald SG, Barnes M (1990) Treatment of radiation- and chemotherapy-induced stomatitis. Otolaryngol Head Neck Surg 102:326-330
31. Barker G, Loftus L, Cuddy P, Barker B (1991) The effects of sucralfate suspension and diphenhydramine syrup plus kaolin-pectin on radiotherapy-induced mucositis. Oral Surg Oral Med Oral Pathol 71:288-293
32. Turhal NS, Erdal S, Karacay S (2000) Efficacy of treatment to relieve mucositis-induced discomfort. Support Care Cancer 8:55-58
33. Dodd MJ, Dibble SL, Miaskowski C, MacPhail L, Greenspan D, Paul SM, Shiba G, Larson P (2000) Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90:39-47
34. Porteder H, Rausch E, Kment G, Watzek G, Matejka M, Sinzinger H (1988) Local prostaglandin E2 in patients with oral malignancies undergoing chemo- and radiotherapy. J Craniomaxillofac Surg 16:371-374
35. Labar B, Mrsic M, Pavletic Z, Bogdanic V, Nemet D, Aurer I, Radman I, Filipovic-Grcic N, Sertic D, Kalenic S et al (1993) Prostaglandin E2 for prophylaxis of oral mucositis following BMT. Bone Marrow Transplant 11:379-382
36. Kuhrer I, Kuzmits R, Linkesch W, Ludwig H (1986) Topical PGE2 enhances healing of chemotherapy-associated mucosal lesions. Lancet 1(8481):623
37. Pretnar J, Glazar D, Mlakar U, Modic M (1989) Prostaglandin E2 in the treatment of oral mucositis due to radiochemotherapy in patients with haematological malignancies. Bone Marrow Transplant 4(Suppl 3):106
38. Duenas-Gonzalez A, Sobrevilla-Calvo P, Frias-Mendivil M, Gallardo-Rincon D, Lara-Medina F, Aguilar-Ponce L, Miranda-Lopez E, Zinser-Sierra J, Reynoso-Gomez E (1996) Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis: a randomized double-blind study. Bone Marrow Transplant 17:809-812
39. Hanson WR, Marks JE, Reddy SP, Simon S, Mihalo WE, Tova Y (1997) Protection from radiation-induced oral mucositis by a mouth rinse containing the prostaglandin E1 analog, misoprostol: a placebo controlled double blind clinical trial. Adv Exp Med Biol 400B:811-818
40. Veness MJ, Foroudi F, Gebski V, Timms I, Sathiyaseelan Y, Cakir B, Tiver KW (2006) Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial. Australas Radiol 50:468-474
41. Mose S, Adamietz IA, Saran F, Thilmann C, Heyd R, Knecht R, Bottcher HD (1997) Can prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis? Am J Clin Oncol 20:407-411
42. Plevova P, Blazek B (1997) Intravenous immunoglobulin as prophylaxis of chemotherapy-induced oral mucositis. J Natl Cancer Inst 89:326-327
43. Abdelaal AS, Barker DS, Fergusson MM (1989) Treatment for irradiation-induced mucositis. Lancet 1(8629):97
44. Leborgne JH, Leborgne F, Zubizarreta E, Ortega B, Mezzera J (1998) Corticosteroids and radiation mucositis in head and neck cancer. A double-blind placebo-controlled randomized trial. Radiother Oncol 47:145-148
45. Pillsbury HC 3rd, Webster WP, Rosenman J (1986) Prostaglandin inhibitor and radiotherapy in advanced head and neck cancers. Arch Otolaryngol Head Neck Surg 112:552-553
46. Osaki T, Ueta E, Yoneda K, Hirota J, Yamamoto T (1994) Prophylaxis of oral mucositis associated with chemoradiotherapy for oral carcinoma by Azelastine hydrochloride (Azelastine) with other antioxidants. Head Neck 16:331-339
47. Rymes N, Glick L, Holmes JA (1996) Topical mesalazine in the treatment of chemotherapy and radiotherapy-induced oral mucositis. Bone Marrow Transplant 18:484
48. Kaushal V, Verma K, Manocha S, Hooda HS, Das BP (2001) Clinical evaluation of human placental extract (placentrex) in radiation-induced oral mucositis. Int J Tissue React 23:105-110
49. Valencia J, Velilla C, Urpegui A, Alvarez I, Llorens MA, Coronel P, Polo S, Bascon N, Esco R (2002) The efficacy of orgotein in the treatment of acute toxicity due to radiotherapy on head and neck tumors. Tumori 88:385-389
50. Stokman MA, Spijkervet FK, Burlage FR, Roodenburg JL (2005) Clinical effects of flurbiprofen tooth patch on radiation-induced oral mucositis. A pilot study. Support Care Cancer 13:42-48
51. Elad S, Ackerstein A, Bitan M, Shapira MY, Resnick I, Gesundheit B, Cohen Y, Diss O, Barak D, Dray L, Or R (2006) A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation. Bone Marrow Transplant 37:757-762
52. Garavito AA, Cardona AF, Reveiz L, Ospina E, Yepes A, Ospina V (2008) Colchicine mouth washings to improve oral mucositis in patients with hematological malignancies: a clinical trial. Palliat Support Care 6:371-376
53. Sonis ST, Peterson RL, Edwards LJ, Lucey CA, Wang L, Mason L et al (2000) Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol 36:373-381
54. Logan RM, Gibson RJ, Sonis ST, Keefe DMK (2007) Nuclear factor-κB (NF-κB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral Oncol 43:395-401
55. Sironi M, Pozzi P, Polentarutti N, Benigni F, Coletta I, Guglielmotti A, Milanese C, Ghezzi P, Vecchi A, Pinza M, Mantovani A (1996) Inhibition of inflammatory cytokine production and protection against endotoxin toxicity by benzydamine. Cytokine 8(9):710-716
56. Sironi M, Milanese C, Vecchi A, Polenzani L, Guglielmotti A, Coletta I, Landolfi C, Soldo L, Mantovani A, Pinza M (1997) Benzydamine inhibits the release of tumor necrosis factor-alpha and monocyte chemotactic protein-1 by Candida albicans-stimulated human peripheral blood cells. Int J Clin Lab Res 27:118-122
57. Lalla RV, Gordon GB, Schubert M, Silverman S Jr, Hutten M, Sonis ST et al (2012) A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy. Support Care Cancer 20:1797-1804